Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF8 antibody

TNFRSF8 Reactivity: Human FACS, IHC, ELISA Host: Mouse Monoclonal CD30-412 unconjugated
Catalog No. ABIN6252191
  • Target See all TNFRSF8 Antibodies
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Reactivity
    • 131
    • 27
    • 18
    • 16
    Human
    Host
    • 87
    • 59
    • 10
    • 4
    • 1
    Mouse
    Clonality
    • 88
    • 71
    • 2
    Monoclonal
    Conjugate
    • 67
    • 13
    • 11
    • 11
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    This TNFRSF8 antibody is un-conjugated
    Application
    • 99
    • 57
    • 56
    • 43
    • 35
    • 27
    • 26
    • 23
    • 13
    • 7
    • 6
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (IHC), ELISA
    Purification
    Protein G affinity chromatography
    Immunogen
    Human CD30 recombinant protein was used as the immungen for this antibody.
    Clone
    CD30-412
    Isotype
    IgG2b kappa
    Top Product
    Discover our top product TNFRSF8 Primary Antibody
  • Application Notes
    ELISA: order BSA-free format for coating

    Flow Cytometry: 0.5-1 μg/million cells

    IF: 1-2 μg/mL

    IHC (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1)

    Prediluted format : incubate for 30 min at RT (2)

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CD30 antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 1  mM EDTA,  pH 7.5-8.5, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.2 mg/mL
    Buffer
    PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Aliquot and Store at -20C. Avoid freez-thaw cycles.
  • Target
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Alternative Name
    CD30 (TNFRSF8 Products)
    Synonyms
    CD30 antibody, D1S166E antibody, Ki-1 antibody, Cd30 antibody, Ki antibody, TNFRSF8 antibody, TNF receptor superfamily member 8 antibody, tumor necrosis factor receptor superfamily, member 8 antibody, TNFRSF8 antibody, Tnfrsf8 antibody
    Background
    The antibody recognizes a single chain glycoprotein of 105/120  kDa, identified as CD30/Ki-1. CD30 is synthesized as a 90  kDa precursor, which is processed in the Golgi complex into a membrane-bound phosphorylated mature 105/120  kDa glycoprotein. In Hodgkin's disease, CD30 antigen is expressed by mononuclear-Hodgkin and multinucleated Reed-Sternberg cells. It is also expressed by the tumor cells of a majority of anaplastic large cell lymphomas as well as by a varying proportion of activated T and B cells. This antibody distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the CD30 positive lymphomas lack the leukocyte common antigen (CD45).
    Gene ID
    943
    UniProt
    P28908
You are here:
Support